Prediction of risk of distant recurrence using the 21-gene recurrence score in node-negative and node-positive postmenopausal patients with breast cancer treated with anastrozole or tamoxifen: a TransATAC study.

Source:http://linkedlifedata.com/resource/pubmed/id/20212256

J. Clin. Oncol. 2010 Apr 10 28 11 1829-34

Download in:

View as

General Info

PMID
20212256